Portola Pharmaceuticals, Inc.
South San Franciso,
Portola Pharmaceuticals, Inc. was founded in 2003 and is headquartered in South San Francisco, CA. We completed an initial public offering in May 2013 and are traded on the Nasdaq Stock Market under the symbol PTLA. We have approximately 90...
NovaBay Pharmaceuticals, Inc.
About the Company
NovaBay Pharmaceuticals is Going Beyond Antibiotics® by developing the next generation of non-antibiotic, anti-microbial drugs. NovaBay has several exciting but distinct products:
Still under development are the company’s...
Sunesis Pharmaceuticals, Inc.
South San Francisco,
Reporting to the Vice President, Regulatory Affairs, this position will manage the day-to-day regulatory activities of assigned projects for compounds under development. These activities include acting as the regulatory...
Ultragenyx Pharmaceutical Inc.
Why Join Us
Ultragenyx is a clinical stage biotechnology company committed to bringing to market novel products for the treatment of rare and ultra-rare diseases with an initial focus on serious debilitating metabolic genetic diseases. Founded in...
Intarcia Therapeutics, Inc.
Reports to: Vice President, Regulatory and Quality
Supervised By: Vice President, Regulatory and Quality
The Director of Regulatory Affairs, CMC is responsible for developing and implementing global regulatory CMC...
CareDx, Inc. (formerly XDx, Inc.), based in Brisbane, California, is a publicly traded molecular diagnostics company focused on the discovery, development and commercialization of high value, non-invasive tests to enhance the care and long-term...